GMMG-HD11/DSMM XXI/64007957MMY3010

NCT07671287 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

399

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Teclistamab
DRUG: Daratumumab
DRUG: Lenalidomide
DRUG: Bortezomib (B)
DRUG: dexamethsone

Sponsor

University of Heidelberg Medical Center